Shots:
- Mendaera has received the US FDA’s 510(k) clearance for Focalist robotic system for ultrasound-guided procedures
- Mendaera will begin a limited launch of its Focalist system in 2025 to initially support urology procedures like PCNL, expanding to other specialties, with full commercialization expected in 2026
- Focalist is designed to support precise & consistent needle placement across various users & clinical settings by integrating handheld robotics, real-time ultrasound, & advanced software, with features like touchscreen targeting, robotic needle positioning, & continuous depth tracking to make medical procedures more approachable & reproducible
Ref: Businesswire | Image: Mendaera | Press Release
Related News:- Johnson & Johnson MedTech Reports the US Launch of VOLT Wrist and Proximal Humerus Plating Systems
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
